A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China
NCT07588880
·
clinicaltrials.gov ↗
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Progressive Familial Intrahepatic Cholestasis
Sponsor
Ipsen